Drug Shortage Report for ACYCLOVIR SODIUM INJECTION

Last updated on 2020-08-17 History
Report ID 111367
Drug Identification Number 02236926
Brand name ACYCLOVIR SODIUM INJECTION
Common or Proper name Acyclovir Sodium Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ACYCLOVIR
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size Vial 20 mL
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2020-04-01
Estimated end date Unknown
Actual end date 2020-08-14
Shortage status Resolved
Updated date 2020-08-17
Company comments Our stock of Acyclovir Sodium Injection 50 mg/mL, 10 mL and 20 mL vials is expected to deplete by August 14, 2020. The product will remain on reduced allocation until stock is depleted.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-08-17 French Compare
v3 2020-08-17 English Compare
v2 2020-04-07 French Compare
v1 2020-04-07 English Compare